Cisplatin plus paclitaxel chemotherapy with or without bevacizumab in postmenopausal women with previously untreated advanced cervical cancer: a retrospective study

BACKGROUND: The aim of this study was to assess the survival outcomes of cisplatin-paclitaxel chemotherapy plus bevacizumab (CPB) versus cisplatin-paclitaxel chemotherapy alone (CPA) in postmenopausal women with previously untreated advanced cervical cancer (CC). METHODS: Consecutive postmenopausal...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Guanghua, Liu, Xiangzhen, Yu, Weiguang, Chen, Meiji, Dong, Lingyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866467/
https://www.ncbi.nlm.nih.gov/pubmed/33549065
http://dx.doi.org/10.1186/s12885-021-07869-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866467/
https://www.ncbi.nlm.nih.gov/pubmed/33549065
http://dx.doi.org/10.1186/s12885-021-07869-7

Ejemplares similares